These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 38192128)

  • 1. Anti-seizure Medications: Challenges and Opportunities.
    Tandon N; Radosavljevic M; Vucevic D; Radenkovic M; Jancic J; Samardzic J
    CNS Neurol Disord Drug Targets; 2024; 23(9):1120-1133. PubMed ID: 38192128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of anti-seizure medication (ASM) use in pediatric patients with surgically managed epilepsy: A retrospective review of data from Boston Children's Hospital.
    Wang S; Rotenberg A; Bolton J
    Epilepsy Res; 2020 Feb; 160():106257. PubMed ID: 32004867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug resistant epilepsy in the United States.
    Raspin C; Faught E; Armand J; Barion F; Pollit V; Murphy J; Danielson V
    J Med Econ; 2023; 26(1):189-199. PubMed ID: 36691763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spanish consensus on the management of concomitant antiseizure medications when using cenobamate in adults with drug-resistant focal seizures.
    Carreño M; Gil-Nagel A; Serratosa JM; Toledo M; Rodriguez-Uranga JJ; Villanueva V
    Epilepsia Open; 2024 Jun; 9(3):1051-1058. PubMed ID: 38573131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What has been the impact of new drug treatments on epilepsy?
    Chen Z; Brodie MJ; Kwan P
    Curr Opin Neurol; 2020 Apr; 33(2):185-190. PubMed ID: 32049739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug-resistant epilepsy in England.
    Raspin C; Shankar R; Barion F; Pollit V; Murphy J; Sawyer L; Danielson V
    J Med Econ; 2021; 24(1):1037-1051. PubMed ID: 34348576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence to anti-seizure medications and self-reported availability and affordability of the medications in Addis Ababa, Ethiopia.
    Shawel B; Berhane Y
    PLoS One; 2024; 19(10):e0299964. PubMed ID: 39388428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The Basis of Medication Therapy for Epilepsy].
    Hanaya R
    No Shinkei Geka; 2023 Jan; 51(1):95-104. PubMed ID: 36682754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-seizure medications for neonates with seizures.
    Abiramalatha T; Thanigainathan S; Ramaswamy VV; Pressler R; Brigo F; Hartmann H
    Cochrane Database Syst Rev; 2023 Oct; 10(10):CD014967. PubMed ID: 37873971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Withdrawal of antiseizure medications - for whom, when, and how?
    Brigo F; Broggi S; Lattanzi S
    Expert Rev Neurother; 2023 Apr; 23(4):311-319. PubMed ID: 36946546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Pharmacology and Clinical Efficacy of Antiseizure Medications: From Bromide Salts to Cenobamate and Beyond.
    Löscher W; Klein P
    CNS Drugs; 2021 Sep; 35(9):935-963. PubMed ID: 34145528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The latest advances in the pharmacological management of focal epilepsies in children: a narrative review.
    Matricardi S; Scorrano G; Prezioso G; Burchiani B; Di Cara G; Striano P; Chiarelli F; Verrotti A
    Expert Rev Neurother; 2024 Apr; 24(4):371-381. PubMed ID: 38433525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends of anti-seizure medication use in pediatric patients in six cities in China from 2013 to 2018.
    Yu L; Feng J; Yu Z; Dai H
    Epilepsy Res; 2020 Nov; 167():106448. PubMed ID: 32916644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescription trends in anti-seizure medications for adult patients with epilepsy in Japan: A retrospective cohort study using the database of health insurance claims between 2015 and 2019.
    Jin K; Obara T; Hirano K; Hirai D; Kiuchi M; Tanaka T; Nakasato N
    Epilepsy Behav; 2022 Sep; 134():108841. PubMed ID: 35901657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of adjunctive cenobamate based on number of concomitant antiseizure medications, seizure frequency, and epilepsy duration at baseline: A post-hoc analysis of a randomized clinical study.
    Rosenfeld WE; Nisman A; Ferrari L
    Epilepsy Res; 2021 May; 172():106592. PubMed ID: 33662894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unanticipated improvement in seizure control in drug-resistant epilepsy- real world observations.
    Moloney PB; Costello DJ
    Seizure; 2021 Jan; 84():60-65. PubMed ID: 33285361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value contribution of cenobamate for the treatment of Focal-Onset Seizures (FOS) in patients with drug-resistant epilepsy (DRE) in Spain through reflective Multi-Criteria Decision Analysis (MCDA).
    Falip M; López González FJ; Martín-Herranz I; Merino-Bohórquez V; Montoya J; Rey Gómez-Serranillos I; Rodriguez Uranga JJ; Ruiz E; Sancho-López A; Trillo Mata JL; Antoni Vallès J; Álvarez-Barón E; Sabaniego J; Subías-Labazuy S; Gil A
    Epilepsy Behav; 2023 Aug; 145():109350. PubMed ID: 37480633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Let food be thy medicine. The interaction between ketogenic diet therapy and anti-seizure medications: A systematic review.
    Armeno ML; Kossoff EH
    Epileptic Disord; 2023 Feb; 25(1):18-27. PubMed ID: 36987562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Withdrawal of antiseizure medications after MRI-Guided laser interstitial thermal therapy in extra-temporal lobe epilepsy.
    Athreya A; Matthews RE; Drane DL; Bonilha L; Willie JT; Gross RE; Karakis I
    Seizure; 2023 Aug; 110():86-92. PubMed ID: 37331198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retention, efficacy, tolerability, and quality of life during long-term adjunctive brivaracetam treatment by number of lifetime antiseizure medications: A post hoc analysis of phase 3 trials in adults with focal seizures.
    Brandt C; Dimova S; Elmoufti S; Laloyaux C; Nondonfaz X; Klein P
    Epilepsy Behav; 2023 Jan; 138():108967. PubMed ID: 36435010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.